From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy

From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy

Traditional cancer therapy methods, especially those directed against specific intracellular targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity and therapeutic resistance. Oncolytic peptides that can induce membrane lysis-mediated cancer cell death and subsequent...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hanmeng Liu, Wei Shen, Wanguo Liu, Zexin Yang, Dengke Yin, Chunsheng Xiao
Format:	Article
Idioma:	English
Publicat:	KeAi Communications Co., Ltd. 2024-01-01
Col·lecció:	Bioactive Materials
Matèries:	Oncolytic polymers Oncolytic peptides Cancer therapy Therapeutic resistance Immunotherapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2452199X23002475

Ítems similars

Perspectives on immunotherapy via oncolytic viruses
per: Alberto Reale, et al.
Publicat: (2019-02-01)

Oncolytic Viral Therapy in Osteosarcoma
per: Thomas Karadimas, et al.
Publicat: (2024-07-01)

Recent progress in combination therapy of oncolytic vaccinia virus
per: Seyedeh Nasim Mirbahari, et al.
Publicat: (2024-03-01)

Neutrophils in oncolytic virus immunotherapy
per: Danya Zhou, et al.
Publicat: (2024-12-01)

Translation of oncolytic viruses in sarcoma
per: Steven I. Robinson, et al.
Publicat: (2024-09-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
per: Daniel H. Ahn, et al.
Publicat: (2017-03-01)

Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model
per: Janne Nestvold, et al.
Publicat: (2017-08-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
per: Elizabeth Robilotti, et al.
Publicat: (2023-09-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
per: Audrey H. Choi, et al.
Publicat: (2016-08-01)

Oncolytic viruses as anticancer vaccines
per: Norman eWoller, et al.
Publicat: (2014-07-01)

Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
per: Andrew eNguyen, et al.
Publicat: (2014-06-01)

A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)
per: Christopher Larson, et al.
Publicat: (2018-09-01)

Oncolytic Viruses as an Adjunct to Immune Checkpoint Inhibition
per: Jacob Ripp, et al.
Publicat: (2022-05-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
per: Kevin A. Cassady, et al.
Publicat: (2016-02-01)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
per: Dyer, A
Publicat: (2021)

Genetic Modifications That Expand Oncolytic Virus Potency
per: Francisca Cristi, et al.
Publicat: (2022-01-01)

Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
per: Zhuo Yan, et al.
Publicat: (2024-07-01)

Oncolytic viruses for cancer immunotherapy
per: Otto Hemminki, et al.
Publicat: (2020-06-01)

Targeting Autophagy for Oncolytic Immunotherapy
per: Lulu Hu, et al.
Publicat: (2017-01-01)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
per: Angelica Loskog
Publicat: (2015-11-01)

Delivery and Biosafety of Oncolytic Virotherapy
per: Lizhi Li, et al.
Publicat: (2020-04-01)

Expression of Oncolytic Adenovirus-Encoded RNAi Molecules Is Most Effective in a pri-miRNA Precursor Format
per: Tereza Brachtlova, et al.
Publicat: (2020-12-01)

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
per: Qing Ji, et al.
Publicat: (2022-08-01)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
per: Alberto Reale, et al.
Publicat: (2021-12-01)

Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy
per: Rakin Tammam Nasar, et al.
Publicat: (2024-06-01)

Oncolytic virus immunotherapy: future prospects for oncology
per: Junaid Raja, et al.
Publicat: (2018-12-01)

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
per: Hai Zou, et al.
Publicat: (2023-01-01)

Oncolytic herpes simplex virus and immunotherapy
per: Wenqing Ma, et al.
Publicat: (2018-12-01)

Portrait of a Leader in Immunotherapeutics<subtitle>Oncolytic viruses for treatment of cancer</subtitle>
per: Akseli Hemminki
Publicat: (2012-08-01)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
per: Yalei Zhang, et al.
Publicat: (2021-05-01)

Oncolytics, Cancer-Fighting Viruses from Past to Future: A Literature Review
per: Seyedeh Nasim Mirbahari, et al.
Publicat: (2024-03-01)

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
per: Jiayi Zeng, et al.
Publicat: (2021-10-01)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
per: Licheng Zhu, et al.
Publicat: (2023-04-01)

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
per: Cristian Capasso, et al.
Publicat: (2016-04-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
per: Jia-Li Zhao, et al.
Publicat: (2024-11-01)

Lung cancer and oncolytic virotherapy——enemy's enemy
per: Zhang Li, et al.
Publicat: (2023-01-01)

Research progress in the treatment of glioblastoma by an oncolytic virus: A narrative review
per: Xiangxiang Shao, et al.
Publicat: (2023-01-01)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
per: Xiangxing Liu, et al.
Publicat: (2022-11-01)

Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment Conversion towards Immunogenicity
per: Assia L. Angelova, et al.
Publicat: (2017-12-01)

Oncolytic viruses in melanoma
per: Camille Robinson, et al.
Publicat: (2022-02-01)